Pharmaceutical Nanotechnology and Drug Delivery Systems Course

Lesson 1 • Biological Barriers to Drug Delivery

Identifies physiological obstacles including membranes, mucus, and the blood-brain barrier. Frames nanotechnology as a strategy to overcome each barrier type.

Lesson 2 • Physicochemical Properties of Nanoparticles

Examines size, shape, charge, and surface chemistry as determinants of nanoparticle behavior. Links these properties to drug loading capacity and biological interaction.

Lesson 3 • Regulatory and Safety Landscape

Introduces safety assessment frameworks and regulatory pathways specific to nanomedicines. Establishes compliance awareness as an integral part of nanotechnology development.

Lesson 4 • Overview of Nanocarrier Classes

Surveys liposomes, polymeric nanoparticles, dendrimers, and inorganic carriers. Orients students to the landscape before detailed study of each system.

Lesson 1 • Stability and Characterization of Lipid Systems

Presents analytical methods for size, zeta potential, and drug release profiling of lipid carriers. Guides students in designing stability studies for regulatory submission.

Lesson 2 • Solid Lipid Nanoparticles and Nanostructured Carriers

Distinguishes solid lipid nanoparticles from nanostructured lipid carriers and explains their drug loading models. Addresses polymorphism and its impact on drug expulsion.

Lesson 3 • Lipid Membrane Biophysics

Covers phospholipid bilayer structure, phase transitions, and membrane fluidity. Connects lipid biophysics to encapsulation efficiency and drug retention.

Lesson 4 • Surface Modification of Lipid Carriers

Covers PEGylation, ligand conjugation, and charge modification strategies. Explains how surface engineering extends circulation time and enables active targeting.

Lesson 1 • Polymeric Micelles and Dendrimers

Covers self-assembly of block copolymer micelles and dendrimer architecture for drug encapsulation. Distinguishes critical micelle concentration from dendrimer generation effects.

Lesson 2 • Stimuli-Responsive Polymeric Systems

Examines pH-, thermo-, redox-, and light-responsive polymers for triggered drug release. Connects stimulus type to disease microenvironment characteristics.

Lesson 3 • Drug-Polymer Interaction and Loading

Analyzes drug-polymer compatibility, encapsulation strategies, and loading efficiency optimization. Introduces computational tools for predicting miscibility.

Lesson 4 • Polymer Selection for Drug Delivery

Reviews natural and synthetic biodegradable polymers and their degradation mechanisms. Links polymer molecular weight and hydrophilicity to drug release kinetics.

Lesson 1 • Carbon-Based Nanomaterials

Reviews fullerenes, carbon nanotubes, and graphene oxide as drug carriers and imaging agents. Addresses functionalization strategies that improve dispersibility and reduce toxicity.

Lesson 2 • Mesoporous Silica Nanoparticles

Examines pore structure, surface area, and gating mechanisms of mesoporous silica for controlled release. Highlights advantages for high drug loading of poorly soluble compounds.

Lesson 3 • Hybrid Organic-Inorganic Nanoplatforms

Explores lipid-coated inorganic cores, polymer-metal conjugates, and core-shell architectures. Demonstrates how hybrid design combines the strengths of multiple material classes.

Lesson 4 • Iron Oxide and Magnetic Nanoparticles

Covers superparamagnetic iron oxide synthesis, coating strategies, and magnetic targeting principles. Connects MRI contrast enhancement to theranostic platform design.

Lesson 1 • Protein Corona and Targeting Interference

Analyzes how serum protein adsorption alters nanoparticle surface identity and targeting efficiency. Presents strategies to minimize corona formation and preserve ligand function.

Lesson 2 • Active Targeting with Ligands

Covers antibody, peptide, aptamer, and small-molecule ligands conjugated to nanocarrier surfaces. Connects receptor expression levels to targeting efficiency and selectivity.

Lesson 3 • Stimuli-Triggered Targeting

Reviews externally applied stimuli including ultrasound, magnetic fields, and light for spatiotemporal drug release. Connects each stimulus modality to clinical feasibility.

Lesson 4 • Passive Targeting and the EPR Effect

Explains the enhanced permeability and retention effect and its dependence on tumor vasculature. Discusses limitations and conditions under which passive targeting is effective.

Lesson 1 • Size and Morphology Analysis

Covers dynamic light scattering, nanoparticle tracking analysis, and electron microscopy for size and shape determination. Addresses sample preparation artifacts and data interpretation.

Lesson 2 • Biological Interaction Assays

Covers cell viability, cellular uptake, and endosomal escape assays for in vitro biological evaluation. Links assay results to formulation optimization decisions.

Lesson 3 • Surface and Chemical Characterization

Presents zeta potential measurement, XPS, FTIR, and NMR for surface and chemical analysis. Connects each technique to verification of surface functionalization and drug loading.

Lesson 4 • In Vivo Imaging and Biodistribution

Introduces fluorescence imaging, PET, SPECT, and MRI for tracking nanoparticles in living systems. Connects imaging modality selection to nanoparticle labeling strategy.

Lesson 1 • Nanoparticle Absorption Across Biological Barriers

Examines oral, pulmonary, transdermal, and parenteral absorption routes for nanoparticles. Connects particle size and surface charge to absorption efficiency at each route.

Lesson 2 • Pharmacokinetic Modeling for Nanoparticles

Introduces compartmental and physiologically based pharmacokinetic models adapted for nanoparticles. Enables students to simulate dosing regimens and predict tissue exposure.

Lesson 3 • Mononuclear Phagocyte System Clearance

Covers opsonization, macrophage uptake, and hepatic and splenic clearance of nanoparticles. Presents stealth strategies that extend systemic circulation half-life.

Lesson 4 • Metabolism and Degradation of Nanocarriers

Reviews enzymatic degradation, hydrolysis, and intracellular processing of biodegradable nanocarriers. Connects degradation rate to drug release timing in vivo.

Lesson 1 • Quality Control and Specifications

Establishes release testing specifications, reference standards, and stability protocols for nanomedicine products. Links specification setting to clinical safety and efficacy data.

Lesson 2 • Regulatory Pathways for Nanomedicines

Examines regulatory classification, guidance documents, and approval pathways for nanomedicine products. Addresses nanosimilar and generic nanomedicine regulatory considerations.

Lesson 3 • Clinical Trial Design for Nanomedicines

Reviews phase I dose escalation, pharmacokinetic sampling, and biomarker strategies specific to nanomedicine trials. Addresses patient selection and safety monitoring considerations.

Lesson 4 • Preclinical Development Strategy

Covers selection of animal models, toxicology study design, and efficacy endpoints for nanomedicines. Connects preclinical data packages to regulatory submission requirements.